These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 20358960)
21. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles]. Xi N; Hou LB Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792 [TBL] [Abstract][Full Text] [Related]
22. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles. Kunii R; Onishi H; Ueki K; Koyama K; Machida Y Drug Deliv; 2008 Jan; 15(1):3-10. PubMed ID: 18197517 [TBL] [Abstract][Full Text] [Related]
23. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny. Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142 [TBL] [Abstract][Full Text] [Related]
24. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles. Yan Y; Fu J; Wang T; Lu X Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940 [TBL] [Abstract][Full Text] [Related]
25. [Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug]. Li FF; Zhang XX; Guo SY; Gan Y; Li J Yao Xue Xue Bao; 2013 Feb; 48(2):291-7. PubMed ID: 23672029 [TBL] [Abstract][Full Text] [Related]
26. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles. Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520 [TBL] [Abstract][Full Text] [Related]
27. Fabrication of gradient optical filter containing anisotropic Bragg nanostructure. Cho B; Um S; Woo HG; Sohn H J Nanosci Nanotechnol; 2011 Aug; 11(8):7163-6. PubMed ID: 22103148 [TBL] [Abstract][Full Text] [Related]
28. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release. Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070 [TBL] [Abstract][Full Text] [Related]
29. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy. Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231 [TBL] [Abstract][Full Text] [Related]
30. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating. McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169 [TBL] [Abstract][Full Text] [Related]
31. Chitosan surface-modified hydroxycamptothecin loaded nanoparticles with enhanced transport across Caco-2 cell monolayer. Zhang L; Sun M; Guo R; Jiang Z; Liu Y; Jiang X; Yang C J Nanosci Nanotechnol; 2006; 6(9-10):2912-20. PubMed ID: 17048498 [TBL] [Abstract][Full Text] [Related]
32. Shape design of high drug payload nanoparticles for more effective cancer therapy. Li W; Zhang X; Hao X; Jie J; Tian B; Zhang X Chem Commun (Camb); 2013 Dec; 49(93):10989-91. PubMed ID: 24136236 [TBL] [Abstract][Full Text] [Related]
33. HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery. Lee H; Uhm S; Shin JW; Jeon HM; Dongbang S; Jung HS; Na YC; Kang C; Kim JS Chem Asian J; 2015 Dec; 10(12):2695-700. PubMed ID: 26373261 [TBL] [Abstract][Full Text] [Related]
34. Enhanced anticancer activity of drug nanoparticles formulated with β-cyclodextrin. Zhan H; Jagtiani T; Liang JF Anticancer Drugs; 2017 Mar; 28(3):271-280. PubMed ID: 27926611 [TBL] [Abstract][Full Text] [Related]
35. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin. Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532 [TBL] [Abstract][Full Text] [Related]
36. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. Knežević NŽ; Lin VS Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330 [TBL] [Abstract][Full Text] [Related]
37. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy. Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434 [TBL] [Abstract][Full Text] [Related]
38. Fabrication of encoded rugate porous silicon interferometer for biosensor. Koh Y; Park J; Kim J; Jang S; Woo HG; Sohn H J Nanosci Nanotechnol; 2010 May; 10(5):3590-4. PubMed ID: 20359006 [TBL] [Abstract][Full Text] [Related]
39. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946 [TBL] [Abstract][Full Text] [Related]
40. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles. Kim C; Kim S; Oh WK; Choi M; Jang J Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]